We are a flexible and nimble group who are ready to assist you with your pain management clinical trials, whatever the size of your organization or study. We have the agility to scale our services to fit your precise requirements.
pain trials in past 5 yearsi
With our unique therapeutic Business Unit structure, we are able to provide tailored operations to ensure you get the precise level of resources you need. We can address the challenges you face in pain management marketing, formed solely as we are of analgesia experts at the cutting edge of CNS clinical research, from our most senior executives through to our CRAs.
We understand current trends in analgesia, and are fully equipped to assist you in the development of new compounds and mechanisms of action in clinical pain management. Our senior personnel will stay with your CNS clinical research development program for the duration, with input and oversight on a daily basis.
We can advise you on the design of your chronic pain research study program, as well as implement your CNS clinical trials. We’ll also have oversight of enrollment data, developments and ways to compete faster in pain management marketing.
In clinical pain management research, where opioids have long been the mainstay of the treatment of moderate-severe pain, there is unfortunately the potential for the abuse and misuse of medication. We understand regulatory requirements for the approval of abuse-deterrent compounds and have the relevant experience in abuse liability studies. We can provide much-needed continuity in this area, throughout the whole CNS clinical research process.
iThis is an estimate of our studies from the last five years that are completed or scheduled to complete for this therapy area.